Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

MLA

David Smith, et al. “Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer.” The New England Journal of Medicine, vol. 366, no. 26, June 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....71942b551cfbc7e66a3ad4a4a5eb8446&authtype=sso&custid=ns315887.

APA

David Smith, Julie R. Brahmer, Leora Horn, F. Stephen Hodi, Mario Sznol, Lieping Chen, Georgia Kollia, Drew M. Pardoll, Jon M. Wigginton, Alan J. Korman, Shruti Agrawal, David F. McDermott, Charles G. Drake, Janis M. Taube, Scott J. Antonia, Robert A. Anders, Jeffrey A. Sosman, Richard D. Carvajal, Ashok Kumar Gupta, … John D. Powderly. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. The New England Journal of Medicine, 366(26).

Chicago

David Smith, Julie R. Brahmer, Leora Horn, F. Stephen Hodi, Mario Sznol, Lieping Chen, Georgia Kollia, et al. 2012. “Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer.” The New England Journal of Medicine 366 (26). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....71942b551cfbc7e66a3ad4a4a5eb8446&authtype=sso&custid=ns315887.